AUSTIN, Texas--(BUSINESS WIRE)--Today, Found, the leading specialized weight care telehealth platform, announced a landmark study published in Obesity Science & Practice, assessing weight loss ...

Please provide your email address to receive an email when new articles are posted on . DENVER — Treatment with a novel therapeutic led to clinically significant improvement in cognition for young ...

A deep learning model performs at the level of an abdominal radiologist in the detection of clinically significant prostate cancer on MRI, according to a study published today in Radiology, a journal ...

Purpose: Anemia, highly common among cancer patients, is often an underlying cause of cancer-related fatigue and other quality-of-life (QOL) deficits. Although randomized clinical trials have shown ...

Full results from REGEN-007 are being held and will be submitted to the American Society of Nephrology 2025 Kidney Week as a late-breaking clinical trial In Group 1 (n=24), kidney function stabilized ...

Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this patient population DATROWAY also demonstrated a highly ...

Please provide your email address to receive an email when new articles are posted on . Demonstrated in this video is the identification of a clinically significant labral injury lesion in a disabled ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the KARDIA-2 Phase 2 study of zilebesiran, an ...

Fear of recurrence among uninsured and underrepresented prostate cancer survivors of the Men's Health Study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...